Trial Profile
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Rapamune
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Jan 2017
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Renal transplant rejection
- Focus Adverse reactions
- Sponsors Pfizer
- 03 Aug 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 22 Jul 2015 Planned End Date changed from 1 Sep 2015 to 1 Jul 2015, as reported by ClinicalTrials.gov.
- 22 Jul 2015 Planned primary completion date changed from 1 Sep 2015 to 1 Jun 2015, as reported by ClinicalTrials.gov.